Rezolute, Inc. Shares Plummet After Disappointing Trial Results Raise Investor Concerns Rezolute, Inc. (NASDAQ: RZLT) faced a staggering 90% drop in share prices amid the failure of its lead drug trial, raising serious investor concerns.

Rezolute, Inc. Shares Plummet After Disappointing Trial Results Raise Investor Concerns #United_States #San_Francisco #Rezolute_Inc #RZLT #sunRIZE_trial